Men's health

Prostate cancer detection. Advancing best practice

Jeremy Grummet



Progress in improving diagnoses for men with aggressive prostate cancer is occurring rapidly on many fronts, not least with regard to early detection of disease and disease recurrence.


Article Extract

Australia is a world leader in the diagnosis of prostate cancer. Clinical guidelines used worldwide recommend a standard process for diagnosing prostate cancer that comprises prostate-specific antigen (PSA) blood testing followed by a random transrectal ultrasound-guided (TRUS) prostate biopsy procedure if the PSA test result is elevated.1 For many reasons this process is no longer best practice, and Australian practice is evolving ahead of the guidelines. Australian urologists and oncologists are adopting new imaging techniques, including prostate-specific membrane antigen positron emission tomography (PSMA PET) scanning (Figure 1), which is discussed below.